Skip to Content

TEMOZOLOMIDE 250 mg (Temozolomide 250 mg)

Pill with imprint TEMOZOLOMIDE 250 mg is Gray & White, Capsule-shape and has been identified as Temozolomide 250 mg. It is supplied by IDT Australia Limited.

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEMOZOLOMIDE 250 mg

Temozolomide 250 mg TEMOZOLOMIDE 250 mg

Temozolomide

Imprint
TEMOZOLOMIDE 250 mg
Strength
250 mg
Color
Gray & White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
IDT Australia Limited
National Drug Code (NDC)
64144-0506
Inactive Ingredients
lactose anhydrous, sodium starch glycolate type A potato, silicon dioxide, stearic acid, tartaric acid, gelatin, methylparaben, propylparaben, sodium lauryl sulfate, ferrosoferric oxide, titanium dioxide, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "TEMOZOLOMIDE 250 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.